Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy. Its short 7.2-hour ...

A project in South Africa aims to reduce demand for rhinoceros horns by making them radioactive. Last summer, Host Marco Werman spoke with Professor James Larkin at the University of the Witwatersrand ...

Around 80% of all diagnostic scans rely on these radioisotopes, highlighting the importance of facilities like the newly ...

Learn about the promising Monopar Therapeutics Inc. MNPR-101 treatment targeting solid tumors and how it aims to reduce ...

NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum’s first-in-class radiopharmaceutical drug, satoreotide BELOIT, Wis. & BERLIN--(BUSINESS WIRE)--NorthStar ...

NorthStar will supply non-carrier added Actinium-225, a radionuclide, for use with Ariceum's first-in-class radiopharmaceutical drug, satoreotide Under the terms of the agreement, NorthStar will ...

Radioisotopes are essential components in the active pharmaceutical ingredients (API) used in new and emerging cancer therapies including molecular radiation. Existing supply chains for these ...

A temporary reduction in the production of radioisotopes, which are mainly used for diagnosing cancer, including prostate and breast cancer, has been resolved. In October, cancer and heart ...

--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC today announced ... and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging.

These radioisotopes can be produced as coproducts from Oklo’s recycling processes. Zeno Power’s novel design enables broad commercial use of RPSs in space and terrestrially. In late 2023 ...

Of the nation’s 288,000 manufacturers, only three-fifths of 1% now use radioisotopes. One major stumbling block is cost. A single steel-thickness gauge sells for about $30,000, and while the ...